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Abstract
For most secretory pathway proteins, crossing the endoplasmic reticulum (ER) membrane is an irreversible process.
However, in some cases this flow can be reversed. For instance, misfolded proteins retained in the ER are retrotranslocated
to the cytosol to be degraded by the proteasome. This mechanism, known as ER associated degradation (ERAD), is exploited
by several bacterial toxins to gain access to the cytosol. Interestingly, some ER resident proteins can also be detected in the
cytosol or nucleus, calreticulin (CRT) being the most studied. Here we show that in Trypanosoma cruzi a minor fraction of
CRT localized to the cytosol. ER calcium depletion, but not increasing cytosolic calcium, triggered the retrotranslocation of
CRT in a relatively short period of time. Cytosolic CRT was subsequently degraded by the proteasome. Interestingly, the
single disulfide bridge of CRT is reduced when the protein is located in the cytosol. The effect exerted by ER calcium was
strictly dependent on the C-terminal domain (CRT-C), since a CRT lacking it was totally retained in the ER, whereas the
localization of an unrelated protein fused to CRT-C mirrored that of endogenous CRT. This finding expands the regulatory
mechanisms of protein sorting and may represent a new crossroad between diverse physiological processes.
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Introduction
Nearly one third of newly synthesized eukaryotic proteins are
targeted to the secretory pathway. After entering the endoplasmic
reticulum (ER) either post- or cotranslationally, most proteins are
glycosylated, disulfide bridges are formed, and tertiary and
quaternary structures acquisition is usually accomplished. At this
stage, properly folded proteins leave the ER and travel to their
final destination. The initial cross of the ER membrane is
commonly a unidirectional process, although in some cases this
flow can be reversed. For instance, proteins unable to acquire a
stable fold are first retained in the ER by the folding quality
control machinery to be next retrotranslocated to the cytosol for
proteasomal degradation [1]. This process, known as ER
associated degradation (ERAD), is exploited by some bacterial
toxins to gain access to the cytosol [2]. These proteins only use the
retrotranslocation capabilities of the ERAD machinery and once
in the cytosol avoid being degraded. This illustrates that
retrotranslocation does not necessarily imply an immediate
degradation. Similarly to bona fide ERAD substrates, those
bacterial toxins usually display low conformational stability,
pointing to a similar recognition mechanism by the ERAD
machinery [3,4]. In addition, some ER resident proteins such as
glucosidase II b (GIIb) subunit, ERp57 (a member of the protein
disulfide isomerase family) and calreticulin (CRT) can also be
found in the cytoplasm and nucleus. The mechanism behind this
anomalous targeting is obscure.
CRT is 46 kDa abundant ER resident protein that fulfils at
least two basic functions [5]. Firstly, due to its capacity to bind
monoglucosylated high mannose glycans, CRT is a central
component of the glycoprotein folding quality control system.
Secondly, CRT can bind high amounts of calcium (,20 ions/
protein) with low affinity (Kd ,2 mM), being one of the main
ER calcium buffers. CRT is formed by three structural domains.
The N-terminal domain (residues 1–173, numbered according
t h es e q u e n c eo fm a t u r eTrypanosoma cruzi CRT, TcCRT) bears
the sugar binding site. This domain is predicted to show a
globular fold composed by two antiparallel beta sheets. The
proline rich or P-domain (residues 174–284) is an extended
hairpin that protrudes from the N-terminal domain. It
participates in glycoprotein binding and interacts with ERp57,
which collaborates in the folding maturation of glycoproteins
bound to CRT [6]. Finally, the C-terminal domain (CRT-C)
(residues 285–380) is highly enriched in negatively charged
residues and is responsible for the calcium buffering activity of
the protein. Although CRT is a typical ER resident protein, it
has been found in several other locations including the cytosol,
nucleus [7,8], secretory granules [9,10], the outer side of the
plasma membrane [11,12] and the extracellular space [13].
These alternative locations are linked with diverse biological
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of the immunogenic response towards dying cancer cells [14]. In
addition, topically applied CRT accelerates wound healing in a
porcine model [15,16]. On the other hand, cytosolic CRT
regulates cell adhesion through its interaction with the cytosolic
tail of integrin alpha subunit [17] and also mediates the nuclear
export of some steroid hormone receptors [7,18,19]. Cytosolic
CRT also regulates the stability or translational rate of some
RNAs, such as angiotensin receptor AT1 [20], rubella virus
RNA [21], C/EBPbeta and C/EBPalfa [22], p21 [23] and
glucose transporter-1 [24]. Although these observations strongly
suggest that CRT can reach the cytosol and nucleus, there is a
persistent controversy on this issue. A good argument in favor of
cytosolic/nuclear CRT is the detection of postranslational
modifications exclusively occurring on those sites. For instance,
CRT has been found to be phosphorylated by src kinase [25]
and PKC [26,27], it also can be modified in Ser/Thr with O-
GlcNAc [28] and arginylated CRT has been found in cytosolic
stress granules [29].
There are currently two models to explain the presence of CRT
in the cytosol. The first one postulates the CRT signal peptide is
suboptimal. According to this model, CRT start to translocate into
the ER during their synthesis, but after cleavage of the signal
peptide some ribosomes detach from the ER membrane and the
synthesis is completed in the cytosol in free ribosomes [30]. The
second mechanism postulates that CRT retrotranslotates to the
cytosol from the ER lumen [31], probably taking advantage of the
ERAD machinery. These models are no mutually exclusive, and
their relative contribution to the pool of cytosolic CRT may
depend on the physiological situation of the cell.
N-glycosylation in T. cruzi (the causative agent of Chagas
disease) starts, at variance with higher eukaryotic organisms, with
the transfer of a high mannose glycan (Man9GlcNAc2) devoid of
glucose residues [32]. This feature was crucial in the discovery of
the enzyme UDP-Glc:glycoprotein glucosyltransferase (UGGT), a
central player in the glycoprotein folding quality control systems.
TcCRT shows structural features similar to those found in other
species. It binds monoglucosylated glycans and it is involved in the
retention of immature species in the ER [33]. In particular,
TcCRT plays an important role in the maturation of cruzipain
(CZ), an abundant lysosomal protease and the first identified
endogenous UGGT substrate [34]. Interestingly, TcCRT induces
in mice an immune response against the host protein, raising the
possibility that chagasic cardiomyopathy may be the outcome of
an autoimmune response triggered by the parasite [35]. Although
TcCRT is located mainly in the ER, histochemical studies have
found it also in the Golgi complex, reservosomes, flagellar pocket,
cell surface, cytosol, nucleus and kinetoplast [36]. The mechanism
behind this heterogeneous localization is unknown.
We recently found that the conformation of CRT-C is affected
by calcium in a concentration range similar to that spanned by the
cation in the ER under physiological fluctuations [37]. In the
presence of micromolar calcium concentrations CRT-C adopts an
extended, random-like conformation, while calcium concentra-
tions on the millimolar range induces a more rigid and compact
structure. This information, combined with the several reports of
cytosolic/nuclear CRT and the current knowledge about ERAD,
suggests a mechanism that may regulates CRT localization within
the cell. According to this model, ER calcium depletion would
trigger a conformational change on CRT-C toward a more
disordered structure. In this state, CRT would be recognized by
the ERAD machinery, which would retrotranslocate the protein to
the cytosol. Here we study the effect of ER calcium concentrations
on the retrotraslocation of TcCRT.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Committee on the Care
and Use of Laboratory Animal of the Fundacio ´n Instituto Leloir
(Permit Number: 2009/08/21JC). Blood extraction was per-
formed under ketamine and xylasine anesthesia, and all efforts
were made to minimize suffering.
Reagents
Calcium ionophore A23187, cyclopiazonic acid (CPA), cyclo-
heximide, proteasome inhibitor MG132, geneticin (G-418), trans-
epoxysuccinyl-l-leucylamido (4-guanidino) butane (E-64), iodoace-
tamide, digitonin and Streptavidin-HRP were from Sigma. Anti-
hemagglutinin (HA) and anti-green fluorescent protein (GFP)
antibodies and 4-acetamido-49-maleimidylstilbene-2,29-disulfonic
acid (AMS) were purchased from Invitrogen. Sulfo N-hydro-
xysulfosuccinimidyl biotin (sulfo-NHS-biotin) was purchased from
Pierce. Antibodies anti-glutamate dehydrogenase (GDH), anti-CZ
and anti-TcCRT were generated in rabbits from proteins either
purified from the parasite (first two) or expressed in E. coli (last
one).
Cells and culture media
T. cruzi CL Brener epimastigotes were grown as described
before [38]. Escherichia coli DH5a was used for cloning experi-
ments. Bacteria were grown in Luria-Bertani medium, 0.5%
NaCl, 1% tryptone (Difco), 0.5% yeast extract (Difco) and
100 mg/ml ampicillin if necessary.
Genomic constructions
All constructions were performed in bacteria using pBlue-
script as vector. They were then subcloned in the trypanoso-
matid expression vector pTEX. The tetrapeptide KEDL-stop
and the HA tag were generated by annealing of the
corresponding primers and refilled with T4 polymerase (primers
used are listed in Table S1). A pBluescript:HA-KEDL-stop was
generated and TcCRT containing (bases 1–1179) or lacking
(bases 1–1041) TcCRT-C was cloned upstream of HA. The
sequence corresponding to TcCRT-C (bases 1040–1179) were
inserted upstream of those of KEDL-stop in pBluescript:KEDL-
stop. The GFP sequence was then inserted upstream of those
corresponding to TcCRT-C or of KEDL-stop in the vector
coding for GFP but lacking TcCRT-C. Finally, the TcCRT
signal peptide was inserted to both constructions (GFP with or
without TcCRT-C) by annealing and refilling with the
corresponding primers.
Cell disruption by freezing and thawing
The procedure employed was that described and characterized
in Labriola et al, 1995. Briefly, cells were twice washed with
0.25 M sucrose, 5 mM KCI and the pellet obtained upon a low
speed centrifugation was kept frozen at 220uC for 48 h, after
which cells were thawed at 4uC and resuspended in 50 mM Tris-
HCl, pH 7.6, 0.15 M NaCl, 1 mM E-64. The suspension was
centrifuged for 10 min at 15,0006 g. The supernatant was then
removed (cytosolic fraction) and the pellet was resuspended in the
above mentioned buffer supplemented with 1% NP-40. The
suspension was centrifuged as above and the supernatant was
removed (ER fraction).
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CL Brener clone (4.10
7 cells) epimastigotes in exponential
growth phase were harvested, washed with phosphate buffered-
saline (PBS), and resuspended in the same solution supplemented
with 0.5 mM MgCl2 and 0.1 mM CaCl2. Parasites were mixed
with 100 mg of the plasmid containing one of the constructions.
The mixture, in a cuvette (0.4-cm electrode GenePulser, Bio-Rad)
was subjected to electroporation (one pulse at 0.4 kV and 500 mF)
in an ElectroCell Manipulator (BTX Electroporation System).
Parasites were then incubated at room temperature for 10 min,
Figure 1. ER calcium mobilization induces TcCRT retrotranslocation. (A) Cellular distribution of TcCRT (lower gel) and BiP (upper gel) with no
treatment or with the addition of DMSO and CPA as indicated. (B) Relative amount of cytosolic TcCRT with respect of total TcCRT of bands shown in
(A). (C) Effect of the calcium ionophore A23187, CPA and/or external added calcium on the cellular distribution of TcCRT. (D) Quantification of the
amount of cytosolic TcCRT with respect of total TcCRT of bands shown in (C). In B and C bars represent the standard error of triplicate measurements.
In all cases the ER containing fractions were diluted ten fold.
doi:10.1371/journal.pone.0013141.g001
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incubated for 48 h. G-418 was then added (250 mg/ml) and
resistant parasites were selected over a 2 month period.
Digitonin treatment
T. cruzi CL Brener clone epimastigotes were treated with
digitonin (0–1 mg/ml) in Eppendorf microcentrifuge tubes as
previously described [39]. The soluble and particulate fractions
were separated by centrifugation at 20,8006g for 2 min at 4uC.
GDH (cytosolic marker), CZ (lysosomal marker) and CRT (ER
marker) were detected in the soluble fractions by Western blot
using the appropriate antibodies.
Labeling of surface proteins
Parasites were incubated with CPA for 20 min at 37uC and
were centrifuged at low speed for 5 min at 4uC. Next, parasites
were washed twice with PBS and resuspended in the same buffer.
The sample was divided in two halves and one half was lysed by
adding 1% NP-40. Amino groups of surface (non-lysed sample) or
total proteins (detergent-treated sample) were labeled for 20 min at
4uC with 1 mM sulfo-NHS-Biotin. Excess reagent was quenched
by adding 5 mM lysine for 30 min. CRT was immunoprecipitated
and biotinylated CRT was detected by Western blot using
Streptavidin-HRP. As a control, this procedure was also employed
to label CRT present in subcellular fractions generated by freezing
and thawing.
Analysis of TcCRT disulfide bridge
To analyze the presence of a disulfide bridge in TcCRT, the ER
and cytosolic fractions (see above cell disruption by freezing and
thawing) were treated with 5 mM iodoacetamide for 5 min at
room temperature to block free Cys residues. Next, the protein
soluble fractions were reduced with 10 mM DTT in the presence
of 8 M urea for 30 min at 37uC and treated with 30 mM AMS for
5 min at room temperature. Samples were then run on SDS-
PAGE and analyzed by Western blot using anti-TcCRT
antiserum.
Results
ER calcium depletion induces CRT retrotranslocation
As a first approach to study the intracellular localization of
TcCRT we separated the ER from the cytosol plus lysosomal
contents by freezing the parasites at 220uC, and thawing the
sample at 4uC followed by centrifugation for 10 min at 15,0006g.
This first supernatant contained the cytosolic plus lysosomal
contents. The pellet was then resuspended in detergent and
centrifuged. The second supernatant contained the lumenal ER
content. This separation method has been characterized before
[40]. Western blots of BiP and of an ER-tagged GFP (ER-GFP)
showed that neither of them was found in the cytosolic plus
lysosomal fractions (Figure 1A). In addition, a cytosolic version of
GFP was completely absent from the ER fraction. These
observations illustrate the efficiency of the cellular fractionation
procedure. In contrast, the presence of TcCRT was evident in
both fractions (Figure 1A). Cytosolic TcCRT accounted for about
2% of the total protein (Figure 1B). To evaluate whether ER
calcium levels could influence TcCRT localization, we studied its
variation resulting from ER calcium mobilization produced by the
inhibition of the ER SERCA pump by CPA. This inhibitor was
used instead of thapsigargin because the SERCA pump of the
parasite is not inhibited by the latter [41]. Incubation with 1 mM
CPA for 20 min promoted a ,2 fold increment in the amount of
cytosolic TcCRT. A similar ratio was obtained when using 5 mM
or 15 mM inhibitor concentration (Figure 1B), suggesting that
maximum inhibition was already reached at 1 mM. This last
condition was routinely used in subsequent experiments. In
addition, parasites were treated for 20 min with 10 mM of the
calcium ionophore A23187 (Figure 1C and D). The amounts of
cytosolic TcCRT using this drug alone or combined with 1 mM
CPA were similar to that resulting from the use of only the last
one. SERCA inhibition diminishes ER calcium levels with a
concomitant increment of cytosolic calcium concentration. To
analyze which of both phenomena (decrease of ER calcium or its
cytosolic increase) triggered TcCRT relocalization, parasites were
incubated with 5 mM CaCl2 and 10 mM A23187. This treatment
promotes an increment of cytosolic calcium without major effects
on its ER concentration. Under this condition the amount of
cytosolic TcCRT was no altered compared with that of untreated
parasites (Figure 1C and D). It may be concluded, therefore, that
TcCRT relocalization was triggered solely by a decrease in ER
calcium levels.
Figure 2. Retrotranslocated TcCRT is degraded by the protea-
some. Cellular fractionation at different time points upon 1 mM CPA
addition alone (A), or with a previous incubation for 1 h with (B)1m M
cycloheximide or (C)1 0mM MG132. (D) Quantification of the fraction of
cytosolic fraction of TcCRT shown in gels A–C. Bars represent the
standard error of triplicate measurements. In all cases the ER containing
fractions were diluted ten fold.
doi:10.1371/journal.pone.0013141.g002
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SERCA inhibition, cells were incubated in the presence of CPA
and harvested at different time points. The increment in cytosolic
CRT observed was relatively rapid, reaching a maximum after
,20 min (Figure 2A and D). To address if the increase of cytosolic
CRT was due to retrotranslocation from the ER or from a faulty de
novo protein synthesis, we treated the parasites with cycloheximide
before inhibiting the SERCA. Similar changes of cytosolic TcCRT
were observed in the presence or absence of the protein synthesis
inhibitor (Figure 2B and D), thus arguing in favor of the
retrotranslocation hypothesis. Lower cytosolic TcCRT levels were
observed in the presence of cycloheximide, thus suggesting that
TcCRT was being degraded in the cytosol.
Cytosolic TcCRT is degraded by the proteasome
The amount of cytosolic TcCRT reached a maximum ,20 min
after ER calcium depletion and diminished to resting levels within
the next 60 min. This behavior indicated that the retrotranslo-
cated protein had been cleared from the cytosol. To study whether
cytosolic TcCRT was degraded by the proteasome, retrotranslo-
cation was stimulated by CPA in the presence of the proteasome
inhibitor MG132. Under this condition cytosolic TcCRT
increased after the addition of CPA and its level remained steadily
high (Figure 2C and D), suggesting that TcCRT concentration in
the cytosol might be regulated by proteasomal degradation.
Calcium induced TcCRT retrotranslocation depends on its
C-terminal domain
The presence of cytosolic CRT in mammalian cells depends on
CRT-C [31]. To address this phenomenon in our system, we
expressed an HA-tagged version of TcCRT with or without
TcCRT-C (Figure 3A). The full length HA-tagged TcCRT
appeared in both cytosolic and ER fractions, whereas the protein
lacking the C-terminal domain was visible only in the last fraction,
as revealed by Western blot using anti-TcCRT antibodies
(Figure 3B). In both cases the endogenous TcCRT appeared in
both compartments, with a distribution similar to that observed in
non-transfected parasites. These results were confirmed using anti-
HA antibodies (Figure 3C). In agreement with the previous
experiments, cytosolic TcCRT was only observed with the whole
protein, whereas the version lacking TcCRT-C was only visible in
the ER fraction. Depletion of calcium from the ER by SERCA
inhibition induced a time dependent increment of the cytosolic
TcCRT of the full length HA-tagged protein (Figure 4A and B)
with kinetic similar to that observed with the endogenous protein
(Figure 1B), whereas the HA-tagged protein lacking TcCRT-C
remained in the ER under all experimental conditions tested
(Figure 4C).
To further explore this issue, we expressed four constructs of
GFP, with or without the addition of TcCRT-C, and targeted
either to the cytosol or the ER. A C-terminal KEDL ER retention
peptide was incorporated to all constructs (Figure 5A). Both GFPs
lacking the signal peptide (i.e., GFP and GFP-C) appeared only in
the cytosol, whereas both ER-targeted GFPs (i.e. ER-GFP and
ER-GFP-C) were detected in the ER fraction (Figure 5B). In
addition, ER-GFP-C was also detected in the cytosolic fraction
with a distribution similar to that of the endogenous TcCRT
(Figure 5B), thus demonstrating that the TcCRT-C is sufficient to
sustain retrotranslocation. Moreover, depletion of ER calcium by
CPA treatment induced an increment of the cytosolic pool of ER-
GFP-C, whereas the cellular distribution of the ER-targeted GFP
lacking TcCRT-C was not affected (Figure 5C). Taken together,
these results showed that the retrotranslocation process and its
response to ER calcium levels exclusively depend on TcCRT-C.
We should mention that the original aim of using GFP was to
follow the retrotranslocation process by confocal microscopy, but
the minor amount of cytosolic GFP compared with that present in
the ER precluded this approach.
In order to corroborate these results we applied a second
cellular fractionation procedure. The second strategy employed
selectively permeabilizes the plasma membrane with digitonin.
Release of the cytosolic marker GDH began when parasites were
incubated with 0.4 mg/ml digitonin, whereas CZ, an abundant
lysosomal marker, did so at 0.6 mg/ml (Figure 6). As permeabi-
lization at 0.4 mg/ml of digitonin only allows the release of a
Figure 3. TcCRT devoid of its C-terminal domain is not retrotranslocated. (A) Constructions of TcCRT employed to address the effect of
TcCRT-C. Cellular localization of constructs shown in (A) revealed by Western blot with (B) anti-TcCRT or (C) anti-HA antibodies. In (B) the endogenous
protein is also visible. TcCRT-DC-HA refers to TcCRT lacking TcCRT-C. In all cases the ER containing fractions were diluted ten fold.
doi:10.1371/journal.pone.0013141.g003
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visible in the cytosolic fraction only after treating parasites with
CPA. Only the HA-tagged versions of TcCRT displaying the C-
terminal domain appeared in the cytosolic fraction, and this was
visible only when CPA was used. Identical results were obtained
using either anti-HA or anti-TcCRT antibodies. Finally, con-
structs with GFP revealed a similar behavior, as the presence of
cytosolic GFP after incubation with CPA was detected only when
the protein was fused to TcCRT-C. Overall, these results fully
agreed with those obtained using the alternative fractionation
method. Furthermore, they show that TcCRT was translocated to
the cytosol and not sorted to lysosomes upon CPA treatment.
It may be speculated that ER calcium mobilization might
promote TcCRT secretion and that this phenomenon may
explain, by cross contamination, the increase observed in cytosolic
TcCRT. Although this suggestion is ruled out by the fact that
parasites were washed twice with PBS before subcellular
fractionation, it might be further speculated that an increased
TcCRT secretion might in turn result in an increased TcCRT
unspecific adherence to T. cruzi plasma membrane, which in turn
would contaminate in some way the cytosolic fraction. To explore
this possibility, parasites were labeled with sulfo-NHS-Biotin, a
membrane impermeable reagent employed to biotinylate external
proteins. The presence of biotinylated TcCRT was analized by
immunoprecipitation of TcCRT followed by Western blot using
Streptavidin-HRP. Only a very small proportion of TcCRT was
biotinylated, probably due to a low fraction of dead, lysed
parasites. More important, the amount of biotinylated TcCRT
was not affected by CPA addition (Figure 7). Sulfo-NHS-biotin
was also employed to asses the proportion of TcCRT present in
the lysosomal and ER fractions. In this case, an increment of
biotinylated TcCRT was clearly observed in the cytosolic fraction
upon CPA treatment (Figure 7). This experiment shows that the
increase of cytosolic TcCRT induced by CPA was a consequence
of its relocalization to the cytosol and not of an increased
association to the plasma membrane and a subsequent contam-
ination of the cytosolic fraction.
The disulfide bridge of cytosolic TcCRT is reduced
Proteins that retrotranslocate from the ER to the cytosol must
be previously unfolded, probably because they cross the ER
membrane through a narrow pore. This implies that proteins
displaying disulfide bridges must be previously reduced in the ER.
TcCRT has a single disulfide bridge between Cys83 and Cys114.
To analyze the presence of this disulfide bridge in TcCRT, the ER
and cytosolic fractions were treated with iodoacetamide to block
free Cys residues. Next, the soluble protein fractions were reduced
with 10 mM DTT in the presence of 8 M urea and treated with
30 mM AMS. This reagent blocks free Cys and adds a molecular
mass of approximately 500 Da to each modified residue, thus
reducing the gel mobility of proteins displaying disulfide bridges.
Clearly, TcCRT migration depended on its cellular localization, as
the protein present in the ER showed a migration slower than that
present in the cytosol (Figure 8). The higher mobility of cytosolic
TcCRT could be due to proteolysis or deglycosylation, but the
identical gel migration of cytosolic and ER samples observed in
Figure 1 ruled out this possibility. This experiment shows that
cytosolic TcCRT is reduced, whereas the protein present in the
ER is oxidized and, furthermore, argues against the possibility that
the former TcCRT could be a result of leakage of the ER protein
during the fractionation procedure.
Discussion
Although CRT resides mainly in the ER lumen, several reports
have found it in other locations such as cytosol, nucleus, secretory
granules, the outer side of the plasma membrane and the
extracellular space. Accordingly, CRT has been associated with
several biological functions, its roles as a lectin/chaperone in the
folding of glycoproteins and as calcium buffer within the ER being
the most prominent. Given the myriad of cellular responses
mediated by calcium, many of the biological effects observed upon
changes in CRT levels might originate from an imbalance of
calcium homeostasis. For this reason, the biological relevance of
cytosolic CRT is controversial.
Here we showed that a minor fraction of TcCRT is present in
the cytosol. The presence of TcCRT in the cytosol may be a
consequence of retrotranslocation or the result of an inefficient
translocation during protein synthesis. The fact that TcCRT
devoid of the C-terminal domain was absent from the cytosol
favors the former interpretation. Aborted ER translocation would
operate during the first steps of protein synthesis and the C-
terminal-truncated TcCRT and the full length protein should be
Figure 4. TcCRT devoid of its C-terminal domain is not
retrotranslocated. Time course distribution of (A) TcCRT-HA or (C)
TcCRT-DC-HA upon addition of 1 mM CPA revealed with anti-HA
antibodies. (B) Relative amount of cytosolic TcCRT-HA of bands shown
in (A). Bars represent the standard error of triplicate measurements. In
all cases the ER containing fractions were diluted ten fold.
doi:10.1371/journal.pone.0013141.g004
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ment of cytosolic CRT content triggered by CPA treatment
occurred even in the absence of protein synthesis also favors the
idea that CRT is retrotranslocated from the ER lumen to the
cytosol. We also found that the amount of protein located in the
cytosol increased upon perturbing ER calcium levels, showing a
relatively fast and transient response. Cytosolic TcCRT levels
peaked about 15–20 min after ER calcium mobilization and the
evidence suggests that the proteasome is involved in the
subsequent clearance of CRT from the cytosol. As these
observations were made with the endogenous protein we can rule
out a mislocalization due to saturation of cellular sorting systems.
We also found that a shorter version of TcCRT lacking the C-
terminal domain was totally retained in the ER, whereas a non
related protein such as GFP fused to this same domain mimicked
TcCRT localization. These results show that ER calcium level
regulates the C-terminal-dependent retrotranslocation of TcCRT.
Cellular fractionation, selective membrane permeabilization and
protein biotinylation methods yielded similar results.
Calcium concentration in the ER varies over two orders of
magnitude, from approximately 5 mM when it is full to about 50–
100 mM after the opening of the ER membrane calcium channels
[42,43]. Strikingly, CRT structure is marginally stable at
physiological temperatures and CRT melting temperature dimin-
ishes from 46.8uC to 43.5uC when calcium concentration
decreases from 1 mM to 10 mM [44]. Similar conditions facilitate
the recognition by CRT of hydrophobic peptides [45]. In addition,
we have recently found that the conformation of CRT-C is
affected by calcium in a concentration range similar to that
spanned in the ER during physiological fluctuations [37]. In the
presence of millimolar calcium concentrations the domain adopts
a rigid and compact structure whereas micromolar calcium
concentrations induce an extended and random-like conforma-
tion. Although those results were obtained using rabbit CRT C-
terminal domain, we suggest that similar conformational changes
occur in TcCRT-C upon calcium concentration variations, as
both the mammalian and protozoan C-terminal domains share
similar sequence features. As bacterial toxins and the ERAD
Figure 5. TcCRT C-terminal domain regulates the calcium response of retrotranslocation. (A) GFP-based constructs used to study the
effect of TcCRT-C on protein localization. (B) Cellular localization of the GFP-based constructs. (C) Time course distribution of the ER-targeted GFP
constructs with (upper gel) or without (lower gel) TcCRT-C after CPA addition. In (B) and (C) ER containing fractions were diluted 10 fold.
doi:10.1371/journal.pone.0013141.g005
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that would favor their unfolding by the ERAD machinery, we
speculate that TcCRT reaches the cytosol through the ERAD
system. However, at variance with ERAD substrates and bacterial
toxins, we propose that CRT retrotranslocation is modulated by
structural modifications triggered by variations of ER calcium
levels. We suggest a model in which ER calcium depletion would
trigger a conformational change on CRT C-terminal domain
toward a more disordered structure. In this state CRT would be
recognized by the ERAD machinery, which would then retro-
translocate the protein to the cytosol. Interestingly, the single
disulfide bridge of TcCRT is reduced when the protein is located
in the cytosol, a likely consequence of its reduction in the ER
previous to retrotranslocation. A member of the protein disulfide
isomerase (PDI) family could be involved in this process. Indeed,
PDI is required for the retrotranslocation of several ERAD
substrates and toxins [46,47]. Interestingly, CRT association in
vitro with ERp57 and PDI is modulated by calcium. Whereas at
high calcium concentration CRT associates with ERp57, lowering
the ion concentration to 100 mM promotes the disassembly of this
Figure 6. Protein localization analyzed using selective membrane permeabilization with digitonin. Detergent concentrations are
indicated in the upper row. Left and right columns indicate the proteins analyzed and the antibodies employed for Western blots, respectively.
doi:10.1371/journal.pone.0013141.g006
Figure 7. Effect of calcium mobilization on the amount of membrane-bound TcCRT. Intact, non-lysed (‘‘out’’) or lysed, detergent-treated
(‘‘total’’) parasites were treated CPA and proteins were modified with sulfo-NHS-biotin. TcCRT was immunoprecipitated and revealed by western blot
using Streptavidin-HRP. As a control, lysosomal and ER fractions were treated similarly.
doi:10.1371/journal.pone.0013141.g007
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calcium-regulated interaction between PDI and CRT depends on
CRT-C. We are currently studying the association between PDI
and CRT in vivo.
CRT is not the only ER resident protein found in the cytosol.
This behavior is also observed for ERp57 and GIIb. ERp57 binds
Stat3 in the cytosol, thus inhibiting Stat3 DNA binding activity
[49], although these results have been recently challenged [50].
ERp57 may also bind to Ref1 [51], a protein involved in DNA
repair, or directly to DNA in the nucleus [52,53]. On the other
hand, GIIb which plays an important role in the processing of N-
glycans in the ER [54], has also been identified as a substrate of
PKC [55,56]. Since PKC activation is usually accompanied by ER
calcium mobilization, it is likely that this signal could trigger the
retrotranslocation of GIIb, thus becoming accessible to PKC. In
addition, it was recently found that GIIb interacts with the
cytosolic tails of IP3 receptor [57] and TRPV5 calcium channel
[58], thus providing further evidence of its cytosolic localization.
GIIb and CRT share some structural features. Both proteins are
marginally stable and present long stretches of negatively charged
residues. Therefore, both proteins could undergo a similar
retrotranslocation processes.
Whether the biological activities of cytosolic TcCRT are similar
to those already described for its mammalian homologue is
presently unknown. We are currently addressing whether ER
calcium depletion also triggers CRT retrotranslocation in
mammalian cells. Preliminary results indicate that this is the case.
Which could be the biological relevance of this process? Nuclear
export of glucocorticoid receptors mediated by CRT requires high
calcium concentrations and is dependent on its C-terminal domain
[59]. These experiments were performed with exogenously added
CRT to semipermeabilized cells, a non-physiological situation.
Nevertheless, these observations combined with the results
presented here could be the basis for an interesting phenomenon,
in which the cellular response to steroid hormones could be
modulated by signals that generate inositol triphosphate. In a cell
activated by a steroid hormone its receptor will be located in the
nucleus. The arrival of a signal that mobilizes ER calcium would
trigger an increment of cytosolic calcium and favor CRT
retrotranslocation, thus fulfilling both known conditions for
CRT-mediated nuclear receptor export. It has been recently
suggested that nuclear export of androgen receptor is independent
of CRT [60]. Given our observations, it would be interesting to
study the effect of ER calcium mobilization on the fate of steroid-
activated nuclear receptors. Finally, evidence presented here and
previous results by others suggest that the regulation of CRT
retrotranslocation by calcium could be a crossroad between
diverse signaling pathways. This model could elucidate diverse and
sometimes contradictory observations regarding this fascinating
protein.
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